[English]

Knowledge will forever govern ignorance, and a people who mean to be their own governors, must arm themselves with the power knowledge gives. James Madison

Walter Keim
Almbergskleiva 64
Rindal, 1.9.2019


Professor Ingrid Melle
UiO Det medisinske fakultet
Institutt for klinisk medisin
Postboks 1039 Blindern
0315 Oslo


Innsyn TIPS data om selvmord


Det refereres til Ingrid Melle et al. 2017. Causes and predictors of premature death in first‐episode schizophrenia spectrum disorders: “Thirty‐one participants (11%) were dead at follow‐up (SMR 11.56; 95% CI: 7.86‐16.42). Sixteen (6%) died by suicide (SMR 46.50, 95% CI: 26.58‐75.51); seven (2.5%) by accidental overdoses or other accidents, and eight (2.8%) from physical illnesses, including three (1%) from cardiovascular illness.” (TIPS study).

Det begjæres innsyn i medhold av offentlighetsloven i de data som ligger bak denne konklusjonen.

Innsyn kan oppklare noen åpne spørsmål og kan styrke tilliten til konklusjonene.

Det refereres i denne sammenheng til Keller et al. 2001 «Study 329» (Wikipedia) der en re-analysis av rådata korrigerte den opprinnelige konklusjonen.

Innsyn har blitt forsøkt før. Robert Whitaker October 11, 2018 Mad in America: “There is now a scientific trail to follow in this exchange. The lead author of the TIPS study doesn’t respond to Gøtzsche’s inquiry (bad science); the editor of the journal that published the article won’t publish a letter raising the question about the deaths (bad science); and the research director for one of the funders doesn’t respond to the question either (more bad science).”


Mvh

Walter Keim
Netizen: http://walter.keim.googlepages.com
Is it possible to enforce access to information in Bavaria
http://wkeim.bplaced.net/files/enforce_access_to_information.html
Complaint to Human Rights Committee Keim/Germany: http://wkeim.bplaced.net/files/Walter%20Keim%20v.%20Germany%20Communication%20to%20Human%20Rights%20Committee%2029%20June%202019.pdf


PS: Cochrane har 5 mars 2018 forsøkt å få svar: TIPS er sponset av bl. a. Eli Lilly.


Oppfølging: